Literature DB >> 26776116

First description of SHV-148 mediated extended-spectrum cephalosporin resistance among clinical isolates of Escherichia coli from India.

Anand Prakash Maurya, Anupam Das Talukdar, Debadatta Dhar Chanda, Atanu Chakravarty, Amitabha Bhattacharjee1.   

Abstract

PURPOSE: The present study was aimed to investigate the genetic context, association with IS26 and horizontal transmission of SHV-148 among Escherichia coli in Tertiary Referral Hospital of India.
METHODOLOGY: Phenotypic characterisation of extended-spectrum beta-lactamases (ESBLs) was carried out as per CLSI criteria. Molecular characterisation of blaSHVand integron was carried out by polymerase chain reaction (PCR) assay and confirmed by sequencing. Linkage of IS26 with blaSHV-148was achieved by PCR. Purified products were cloned on pGEM-T vector and sequenced. Strain typing was performed by pulsed field gel electrophoresis with Xba I digestion. Transferability experiment and antimicrobial susceptibility was performed.
RESULTS: A total of 33 isolates showed the presence of SHV-148 variant by sequencing and all were Class 1 integron borne. PCR and sequencing results suggested that all blaSHV-148 showed linkage with IS26 and were present in the upstream portion of the gene cassette and were also horizontally transferable through F type of Inc group. Susceptibility results suggest that tigecycline was most effective.
CONCLUSION: The present study reports for the first time of SHV-148 mediated extended spectrum cephalosporin resistance from India. Association of their resistance gene with IS26 and Class 1 integron and carriage within IncF plasmid signifies the potential mobilising unit for the horizontal transfer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26776116     DOI: 10.4103/0255-0857.174110

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  2 in total

1.  Genetic diversity study of various β-lactamase-producing multidrug-resistant Escherichia coli isolates from a tertiary care hospital using ERIC-PCR.

Authors:  Jayanti Jena; Nagen Kumar Debata; Rajesh Kumar Sahoo; Mahendra Gaur; Enketeswara Subudhi
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

2.  Resistance to extended-spectrum cephalosporins in Escherichia coli and other Enterobacterales from Canadian turkeys.

Authors:  Jonathan Moffat; Gabhan Chalmers; Richard Reid-Smith; Michael R Mulvey; Agnes Agunos; Julie Calvert; Ashley Cormier; Nicole Ricker; J Scott Weese; Patrick Boerlin
Journal:  PLoS One       Date:  2020-09-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.